Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Shanghai Weishen Pharmaceutical

Request full access

Innovative pharmaceutical solutions enhancing patient care through cutting-edge research and development

Wuhan, ChinaFounded 2016Biotech & Life Sciences

About Shanghai Weishen Pharmaceutical

WV Pharm is a pioneering pharmaceutical company dedicated to advancing patient care through innovative research and development. The company operates in the healthcare and pharmaceutical market, focusing on creating new and effective medications that address unmet medical needs. WV Pharm serves a diverse range of clients, including hospitals, clinics, and individual patients, providing them with high-quality pharmaceutical products. The business model revolves around extensive research and development, clinical trials, and the subsequent commercialization of new drugs. Revenue is generated through the sale of these medications to healthcare providers and patients. The company also invests in partnerships and collaborations with other healthcare entities to expand its product offerings and market reach.

Source: Dealroom company data

At a glance

Status
Operational
Open positions
None listed
Dealroom signal
19.3/100
Industry
Health
Sub-industry
Pharmaceutical, BioTechnology
Sector
Biotechnology, Biotech and Pharma, DT and LS, science-based
Business model
Manufacturing
Client focus
B2B
Links
Website

Funding history

2 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES A✓Equity / VC Jun 2025 — — Undisclosed ↗
SEED✓Equity / VC Dec 2021 $14M $55M Rongsheng Venture Capital · Zhangke Herun Venture Capital · Wenzhou Investment ↗
Showing the latest 2 of 2 recorded eventsBook a demo for the full funding history →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Shanghai Weishen Pharmaceutical in the Wuhan ecosystem

Live from Dealroom

The Shanghai Weishen Pharmaceutical office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

3 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed3 investors entered at this stage

  • Zhangke Herun Venture Capital
  • Wenzhou Investment
  • Rongsheng Venture Capital
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇨🇳 China · Wuhan HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Shanghai Weishen Pharmaceutical on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Shanghai Weishen Pharmaceutical’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.